Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

34.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 709,100
  • Market Cap: £123.81m

Latest ShareCast News

Creo device used in 'groundbreaking' lung cancer procedure

By Josh White

Date: Friday 01 Mar 2024

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

Creo Medical FY revenues up double digits

By Iain Gilbert

Date: Wednesday 07 Feb 2024

(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.

Creo launches 'Speedboat Ultraslim' with first UK procedure

By Josh White

Date: Wednesday 13 Dec 2023

(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 34.25p
Change Today -0.50p
% Change -1.44 %
52 Week High 48.10
52 Week Low 23.25
Volume 709,100
Shares Issued 361.48m
Market Cap £123.81m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.24% below the market average20.24% below the market average20.24% below the market average20.24% below the market average20.24% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Price Trend
20.91% above the market average20.91% above the market average20.91% above the market average20.91% above the market average20.91% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Income Not Available
Growth
40.61% above the market average40.61% above the market average40.61% above the market average40.61% above the market average40.61% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
17:08 36,389 @ 34.25p
16:30 15,000 @ 34.38p
16:29 580 @ 34.45p
16:10 29,500 @ 34.50p
16:03 236,617 @ 33.51p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page